CurrentBlue Cross Blue Shield - OklahomaPolicy CPCP017

Wasted/Discarded Drugs and Biologicals Policy

Defines billing, coding, and reimbursement practices for discarded or wasted drugs and biologicals for providers and suppliers under Blue Cross Blue Shield of Oklahoma plans.

Policy Summary

PayerBlue Cross Blue Shield - Oklahoma

PolicyWasted/Discarded Drugs and Biologicals Policy

Policy CodePolicy CPCP017

Change TypeContent additions and clarifications (modifier usage, supplier guidance, exclusions, references)

Effective DateNovember 25, 2025

Next Review Date

Key ActionWhen billing discarded drug amounts, submit documentation showing dose administered and discarded amount, bill units in CPT/HCPCS multiples, and append JW or JZ modifiers as appropriate.

SourceLink

POLICY UPDATE CHANGES

JZ Modifier Usage section added.

Suppliers - Modifier Usage section added.

When Drugs and Biologicals are not Eligible for Reimbursement section added/expanded.

Additional Resources and References updated.

CPCP017Policy identifier

1.0Version

2025-11-25Plan effective

2025-08-19Committee approval

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

2019-2025Update history

Reimbursement Criteria and Exclusions

Reimbursement criteria and exclusions

Reimbursement for discarded amounts from single‑use vials/packages is allowed when all documentation, billing, and product eligibility requirements below are met. Certain scenarios are explicitly excluded.

ALL of the following

Billing and coding: Discarded amount must be billed on a separate line with the correct CPT/HCPCS code, correct units, and the JW modifier for all non‑inpatient places of service.
Documentation: Medical record must clearly document dose administered, discarded amount, exact date and time of administration, and the reason for wastage.
Single‑use product requirement: The drug or biological must be supplied in a single‑use vial or single‑use package and the discarded portion must not be administered to another patient or member.
Appropriate administration: The drug or biological must have been administered appropriately for the member's medical condition and any unused portion discarded.
Units and dose limits: Units billed must correspond with the smallest dose or vial available for purchase from the manufacturer; total billed dose (administered + discarded) must not exceed the amount indicated on the vial or package label.
NDC reporting when applicable: When billing for NDC‑based reimbursement, include the NDC and ensure NDC units correspond to CPT/HCPCS units (units of measure such as mL, gram, or vial count).

Excluded scenarios (NOT eligible for reimbursement):

Discarded amounts from multi‑use vials or multi‑use packages (multi‑dose containers) are not eligible for JW reimbursement.
Overfill or quantities exceeding the manufacturer's labeled package volume or mass (‘overfill’) are not eligible for reimbursement.
Use of JW modifier for hospital inpatient admissions is not eligible for reimbursement under this policy.
Wastage resulting from missed appointments, member change of mind, provider mishandling or improper reconstitution, shipping damage, storage outside manufacturer requirements, theft, device malfunction (e.g., OnPro/Onbody device issues), or products not FDA approved or not meeting Medical Policy criteria are not eligible for reimbursement.

Operational: JW modifier should only be applied to the amount discarded; suppliers and providers are required to document the discarded amount in the member's medical record.

Modifiers, Codes, and Unit Rules

Covered HCPCS Codes and ModifiersHCPCSCovered

JW	Modifier indicating drug amount discarded/not administered
JZ	Modifier indicating no discarded amount from single-use vial/package
J9312	Rituximab, 10mg
J9355	Trastuzumab, 10mg

Modifier GuidanceModifier

JW	Append the JW modifier on claims for discarded drugs and biologicals from single-use vials and/or single-use packages; billed on a separate line with correct CPT/HCPCS code and units for all non-inpatient places of service; document discarded amount in medical record.
JZ	Indicates no discarded amounts from single-use vials or packages (usage guidance added in policy).

Unit rounding rule

Unit rounding ruleIf amount administered is not a multiple of the CPT/HCPCS unit, round to the next highest unit in the CPT/HCPCS description; bill the discarded amount on a separate line with the correct CPT/HCPCS code and modifier; total dose (administered + wasted) must not exceed the vial amount.

Billing units requirementUnits of service must be billed in multiples of the dosage specified in the full CPT/HCPCS description.

Separate-line billingDiscarded amount must be billed on a separate claim line from the administered amount using correct CPT/HCPCS code, units, and applicable modifier (e.g., JW) for non-inpatient settings.

Total dose limitThe combined administered and discarded quantities must not exceed the manufacturer vial/package labeled amount.

Documentation, Claim Review, and Billing Requirements

Documentation Required

Documentation and Claim Review

Providers are responsible for submission of accurate documentation of services performed and are expected to submit claims using valid code combinations from HIPAA-approved code sets. Claims are subject to code edit protocols and may be reviewed against plan documents, provider contract language, medical policies, clinical payment and coding policies, and coding software logic. Upon request, the provider must submit any additional documentation to support the claim.

Providers must code claims appropriately according to industry standard coding guidelines (e.g., UB Editor, AMA CPT, HCPCS, ICD-10-CM/PCS, NDCs, DRG guidelines, CMS NCCI policies and edits).
Claims that do not adhere to coding and billing policies may delay or impact processing and reimbursement.
The Plan reserves the right to request supporting documentation and to review claims for medical necessity and contractual compliance.

Key Definitions

Drug Waste

DefinitionDrug Waste: The partial vial, package, or product of drug or biologic that is discarded and not administered to any member.

Not eligible when reusedDiscarded portions that are subsequently administered to another patient are not considered wasted for billing purposes.

Documentation expectationMedical record must document dose administered, discarded amount, date/time, and reason for wastage when billing for discarded drug.

JW Modifier

DefinitionJW Modifier: Indicates the amount of drug or biological discarded and not administered to any member; used to report discarded amounts.

Billing usageWhen used, the discarded amount must be billed on a separate line with correct CPT/HCPCS code and units and meet documentation criteria.

Policy Summary

PayerBlue Cross Blue Shield - Oklahoma

PolicyWasted/Discarded Drugs and Biologicals Policy

Policy CodePolicy CPCP017

Change TypeContent additions and clarifications (modifier usage, supplier guidance, exclusions, references)

Effective DateNovember 25, 2025

Next Review Date

Key ActionWhen billing discarded drug amounts, submit documentation showing dose administered and discarded amount, bill units in CPT/HCPCS multiples, and append JW or JZ modifiers as appropriate.

SourceLink

On This Page

Billing Rule

Billing Documentation Requirements for Wasted/Discarded Drugs

For claims involving wasted or discarded drugs and biologicals, providers must include specific billing documentation demonstrating the drug product preparation and measurement of both administered and wasted amounts. Reimbursement is determined by the member's plan documents; the Plan may request supporting documentation. Providers are encouraged to minimize product waste through efficient administration.

Medical records must document the drug product preparation for any claim that includes wasted or discarded drug/biological units.
When billing drugs, units of service must be billed in multiples of the dosage specified in the full CPT/HCPCS description.
If the amount administered is not an exact multiple of the CPT/HCPCS code unit, round up to the next highest unit in the CPT/HCPCS description for that code.
The total dose billed (administered plus wasted/discarded) must not exceed the vial amount.
Failure to include required preparation and waste documentation may result in claim adjustment or denial.

Place of serviceJW modifier is appropriate for non-inpatient places of service per policy criteria.

JZ Modifier

DefinitionJZ Modifier: Indicates that no discarded amounts were derived from a single‑use vial or single‑use package (i.e., no waste).

Single‑use contextApplied when the product was from a single‑use vial/package and no portion was discarded.

Contrast to JWUsed to denote absence of waste, whereas JW denotes an amount discarded and billed separately.

Multi‑use vials/packages

DefinitionMulti‑use vials/packages: A drug or biologic package that allows more than one dose to be withdrawn for administration by injection or infusion.

JW not appropriateUse of modifier JW is not appropriate for drugs that are from multi‑dose vials or packages — discarded amounts from multi‑dose vials are not eligible for JW billing.

Reimbursement exclusionDiscarded amounts from multi‑use vials/packages are listed among non‑reimbursable scenarios in the policy.

Overfill

DefinitionOverfill: Any excess product (overfill) provided without charge to the provider and not billable.

Billing prohibitionProviders may not bill for overfill harvested from single‑use containers, including overfill pooled from more than one container, because it does not represent a cost to the provider.

Not considered wasteOverfill is considered manufacturer‑provided excess, not a discarded cost eligible for reimbursement.

Single‑use vials/packages

DefinitionSingle‑use vials/packages: A drug or biologic package that allows only one (1) dose to be withdrawn for administration by injection or infusion.

Eligibility for discarded‑amount reimbursementPolicy permits reimbursement for discarded amounts only when the drug administered is from a single‑use vial/package and documentation criteria are met.

Documentation requirementWhen billing for discarded amounts from single‑use containers, the medical record must document dose administered, discarded amount, date/time, and reason for wastage.